Drug Profile
Cedelizumab
Alternative Names: Monoclonal antibody OKT-4; OKT-4 antibody; OKT-4A; Orthoclone OKT4; Orthoclone OKT4A; RWJ 49004Latest Information Update: 08 Aug 2002
Price :
$50
*
At a glance
- Originator Ortho-McNeil
- Class Monoclonal antibodies
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Transplant rejection